EGF and breast carcinoma: For two human estrogen-responsive breast cancer cell lines (namely, MCF-7 and ZR-75-1 cells), it has been shown that (+)-aeroplysinin-1 blocks their EGF-dependent proliferation, claiming that this observed effect was caused by an inhibitory effect of (+)-aeroplysinin-1 on EGFR phosphorylation [44].